Results 11 to 20 of about 96,790 (240)

Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome

open access: yesToxins, 2022
The serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle.
Kyu-Ho Yi, Ji-Hyun Lee, Hee-Jin Kim
doaj   +1 more source

Nicolau Syndrome after Intramuscular Injection: 3 Cases [PDF]

open access: yesArchives of Plastic Surgery, 2012
Nicolau syndrome is a rare complication of intramuscular injection consisting of ischemic necrosis of skin, soft tissue, and muscular tissue that arises locoregionally.
Seok-Kwun Kim   +2 more
doaj   +2 more sources

The Effect of the Ventrogluteal Injection Training on the Knowledge Levels and Preferences of Health Professionals

open access: yesForbes Tıp Dergisi, 2020
INTRODUCTION: This study is aimed to determine the effect of ventrogluteal injection training on the health professionals' knowledge levels and preferences about the use of the ventroglu- teal region for intramuscular injections.
Ahu Çırlak, Nur Temiz, Merve Başol
doaj   +1 more source

Intramuscular BoNT/A injections cause an inflammatory response in the muscle tissue of rats

open access: yesEuropean Journal of Inflammation, 2021
Objectives The purpose of the present study was to investigate whether intramuscular BoNT/A injections cause an systemic inflammatory response and a local inflammatory response in the muscle tissue.
Jessica Pingel   +3 more
doaj   +1 more source

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. [PDF]

open access: yes, 2020
BACKGROUND: Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia.
Abass, KM   +31 more
core   +3 more sources

Safety and efficacy of a propofol and ketamine based procedural sedation protocol in children with cerebral palsy undergoing botulinum toxin A injections. [PDF]

open access: yes, 2019
Background Pediatric patients with cerebral palsy (CP) often undergo intramuscular botulinum toxin (BoNT‐A) injections. These injections can be painful and may require procedural sedation.
Abu-Sultaneh, Samer   +4 more
core   +1 more source

Determination of safe sites of intramuscular arm injections and its relevance to the community

open access: yesJournal of Family Medicine and Primary Care, 2022
Background and Introduction: Intramuscular injections are usually given in the arm or the gluteal region. Needle insertions done through the intramuscular route in the arm are almost always administered at a point 1 – 2 cm above the insertion of the ...
S Surraj   +2 more
doaj   +1 more source

Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines [PDF]

open access: yes, 2016
The aim of this study was to evaluate the bioequivalence of two commercial long-acting formulations based on oxytetracycline (OTC) hydrochloride between the reference formulation (Terramycin LA, Pfizer) and a test formulation (Cyamicin LA, Fort Dodge ...
Fernandez Lastra, Cecilia   +7 more
core   +4 more sources

TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243] [PDF]

open access: yes, 2002
Agitated or violent patients constitute 10% of all emergency psychiatric treatment. Management guidelines, the preferred treatment of clinicians and clinical practice all differ.
A Jablensky   +21 more
core   +3 more sources

Safety of combined salivary gland and multilevel intramuscular onabotulinumtoxinA injections with and without ethanol in pediatric patients with cerebral palsy: A retrospective study

open access: yesJournal of Pediatric Rehabilitation Medicine, 2019
OBJECTIVE: To evaluate the safety of combining salivary gland onabotulinumtoxinA (BTX-A) injections for sialorrhea with intramuscular BTX-A injections for spasticity in the same procedure.
Hannah Shoval   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy